Drug Delivery for Treatment of Inner Ear Disease: Current State of Knowledge

Delivery of medications to the inner ear has been an area of considerable growth in both the research and clinical realms during the past several decades. Systemic delivery of medication destined for treatment of the inner ear is the foundation on which newer delivery techniques have been developed. Because of systemic side effects, investigators and clinicians have begun developing and using techniques to deliver therapeutic agents locally. Alongside the now commonplace use of intratympanic gentamicin for Meniere's disease and the emerging use of intratympanic steroids for sudden sensorineural hearing loss, novel technologies, such as hydrogels and nanoparticles, are being explored. At the horizon of inner ear drug-delivery techniques, intracochlear devices that leverage recent advances in microsystems technology are being developed to apply medications directly into the inner ear. Potential uses for such devices include neurotrophic factor and steroid delivery with cochlear implantation, RNA interference technologies, and stem-cell therapy. The historical, current, and future delivery techniques and uses of drug delivery for treatment of inner ear disease serve as the basis for this review.

[1]  H. Silverstein,et al.  Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial. , 1998, The American journal of otology.

[2]  I. Pyykkö,et al.  Distribution of lipid nanocapsules in different cochlear cell populations after round window membrane permeation. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.

[3]  W. Gao,et al.  Isolation, growth and differentiation of hair cell progenitors from the newborn rat cochlear greater epithelial ridge , 2007, Journal of Neuroscience Methods.

[4]  Alfred L. Nuttall,et al.  Osmotic pump implant for chronic infusion of drugs into the inner ear , 1993, Hearing Research.

[5]  G. Rettig,et al.  Progress Toward In Vivo Use of siRNAs-II , 2006, Molecular Therapy.

[6]  A. Salt.  Pharmacokinetics of Drug Entry into Cochlear Fluids. , 2005, The Volta review.

[7]  S. Heller,et al.  The potential role of endogenous stem cells in regeneration of the inner ear , 2007, Hearing Research.

[8]  H. Silverstein,et al.  Inner ear perfusion and the role of round window patency. , 1997, The American journal of otology.

[9]  R. Stokroos,et al.  Treatment of Idiopathic Sudden Sensorineural Hearing Loss with Antiviral Therapy: A Prospective, Randomized, Double-Blind Clinical Trial , 2003, The Annals of otology, rhinology, and laryngology.

[10]  Juichi Ito, Ken Kojima, Saburo Kawaguchi.  Survival of Neural Stem Cells in the Cochlea , 2001 .

[11]  David Erickson,et al.  Electrokinetic microfluidic devices for rapid, low power drug delivery in autonomous microsystems. , 2008, Lab on a chip.

[12]  Jas. Hardie Neil.  Sudden deafness. , 1951, The New Zealand medical journal.

[13]  T. Ito,et al.  Appearance of bax protein after preoperative chemoradiotherapy is a prognostic factor in maxillary cancer. , 2001, Acta oto-laryngologica.

[14]  C. L. Schmidt,et al.  10 Years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of Morbus Menière , 1978, Archives of oto-rhino-laryngology.

[15]  R. Stokroos,et al.  Antiviral treatment of idiopathic sudden sensorineural hearing loss: a prospective, randomized, double-blind clinical trial. , 1998, Acta oto-laryngologica.

[16]  David C. Martin,et al.  Localized cell and drug delivery for auditory prostheses , 2008, Hearing Research.

[17]  Tejal A. Desai,et al.  Microfabrication of Multilayer, Asymmetric, Polymeric Devices for Drug Delivery , 2005 .

[18]  Josef M. Miller,et al.  Technical report: chronic and acute intracochlear infusion in rodents , 2000, Hearing Research.

[19]  Huawei Li,et al.  Pluripotent stem cells from the adult mouse inner ear , 2003, Nature Medicine.

[20]  C. Petit,et al.  Cells of adult brain germinal zone have properties akin to hair cells and can be used to replace inner ear sensory cells after damage , 2008, Proceedings of the National Academy of Sciences.

[21]  Mark G. Allen,et al.  Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Bruce J. Gantz,et al.  Combined acoustic and electric hearing: Preserving residual acoustic hearing , 2008, Hearing Research.

[23]  J. Ito,et al.  Drug delivery systems for the treatment of sensorineural hearing loss , 2007, Acta oto-laryngologica. Supplementum.

[24]  M. Paparella,et al.  Meniere's disease , 2008, The Lancet.

[25]  B. Grady,et al.  Magnetic Nanoparticles: Inner Ear Targeted Molecule Delivery and Middle Ear Implant , 2006, Audiology and Neurotology.

[26]  M. Graham,et al.  Chemical and physical labyrinthectomy for Meniere's disease. , 2002, Otolaryngologic clinics of North America.

[27]  Hao Jiang,et al.  A Novel Controlled Local Drug Delivery System for Inner Ear Disease , 2008, The Laryngoscope.

[28]  Bruce J. Gantz,et al.  Acoustic plus Electric Speech Processing: Preliminary Results of a Multicenter Clinical Trial of the Iowa/Nucleus Hybrid Implant , 2006, Audiology and Neurotology.

[29]  A. Salt,et al.  Local inner-ear drug delivery and pharmacokinetics. , 2005, Drug discovery today.

[30]  K. Dietz,et al.  Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: Basis for planning randomized controlled trials , 2005, Acta oto-laryngologica.

[31]  L. Parnes,et al.  Treatment of sudden sensorineural hearing loss: I. A systematic review. , 2007, Archives of otolaryngology--head & neck surgery.

[32]  Jan Kiefer,et al.  Combined Electric and Acoustic Stimulation of the Auditory System: Results of a Clinical Study , 2005, Audiology and Neurotology.

[33]  M. Leinung,et al.  Substance distribution in a cochlea model using different pump rates for cochlear implant drug delivery electrode prototypes , 2006, Hearing Research.

[34]  A. Gamst,et al.  Intratympanic Gentamicin Therapy for Ménière’s Disease: A Meta-analysis , 2004, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[35]  John T Santini,et al.  Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device , 2006, Nature Biotechnology.

[36]  I. Doweck,et al.  Acyclovir in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss , 2003, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[37]  R. Battista.  Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss , 2004, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[38]  Y. Tabata,et al.  Novel Therapy for Hearing Loss: Delivery of Insulin-Like Growth Factor 1 to the Cochlea Using Gelatin Hydrogel , 2007, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[39]  H. Silverstein,et al.  Silverstein Microwick™ for treatment of inner ear disease , 2001 .

[40]  R. Hartmann,et al.  Application of a Corticosteroid (Triamcinolon) Protects Inner Ear Function after Surgical Intervention , 2007, Ear and hearing.

[41]  Ryosei Minoda,et al.  Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals , 2005, Nature Medicine.

[42]  D. Tucci,et al.  Treatment of Sudden Sensorineural Hearing Loss with Systemic Steroids and Valacyclovir , 2002, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[43]  Richard J. H. Smith,et al.  In vitro and in vivo suppression of GJB2 expression by RNA interference. , 2005, Human molecular genetics.

[44]  H. Silverstein,et al.  Long-Term follow-up after Gentamicin Application via the Silverstein MicroWick in the Treatment of Ménière's Disease , 2006, Ear, nose, & throat journal.

[45]  J. R. Holt,et al.  Differential Distribution of Stem Cells in the Auditory and Vestibular Organs of the Inner Ear , 2007, Journal of the Association for Research in Otolaryngology.

[46]  A. Eshraghi,et al.  Local Dexamethasone Therapy Conserves Hearing in an Animal Model of Electrode Insertion Trauma-Induced Hearing Loss , 2007, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[47]  Bruce J Gantz,et al.  Combining acoustic and electrical hearing. , 2003, The Laryngoscope.

[48]  Ramón Hinojosa-González,et al.  Dexamethasone Inner Ear Perfusion by Intratympanic Injection in Unilateral Ménière's Disease: A Two-year Prospective, Placebo-Controlled, Double-blind, Randomized Trial , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[49]  Longitudinal Results With Intratympanic Dexamethasone in the Treatment of Ménière's Disease , 2008, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[50]  R. Altschuler,et al.  Delayed neurotrophin treatment following deafness rescues spiral ganglion cells from death and promotes regrowth of auditory nerve peripheral processes: Effects of brain‐derived neurotrophic factor and fibroblast growth factor , 2007, Journal of neuroscience research.

[51]  Huawei Li,et al.  Engraftment and differentiation of embryonic stem cell-derived neural progenitor cells in the cochlear nerve trunk: growth of processes into the organ of Corti. , 2006, Journal of neurobiology.

[52]  D. Poe,et al.  Efficacy of Increased Gentamicin Concentration for Intratympanic Injection Therapy in Ménière's Disease , 2002, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[53]  D. Beebe,et al.  A valved responsive hydrogel microdispensing device with integrated pressure source , 2004, Journal of Microelectromechanical Systems.

[54]  M. Behlke,et al.  Advances in Molecular and Cellular Therapies for Hearing Loss. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[55]  H. Staecker,et al.  Topical steroid therapy using the Silverstein Microwick™ in sudden sensorineural hearing loss after failure of conventional treatment , 2007, Acta oto-laryngologica.

[56]  P. Weisskopf,et al.  Transtympanic Versus Sustained‐Release Administration of Gentamicin: Kinetics, Morphology, and Function , 2001, The Laryngoscope.

[57]  A. Eshraghi,et al.  Dexamethasone Base Conserves Hearing from Electrode Trauma‐Induced Hearing Loss , 2008, The Laryngoscope.

[58]  T. Stöver,et al.  The biological effects of cell-delivered brain-derived neurotrophic factor on cultured spiral ganglion cells , 2007, Neuroreport.

[59]  C. Klingmann,et al.  Transsynaptic delivery of nanoparticles to the central auditory nervous system , 2007, Acta oto-laryngologica.

[60]  H. Silverstein,et al.  Transtympanic perfusion: indications and limitations , 2004, Current opinion in otolaryngology & head and neck surgery.

[61]  S. O'Leary,et al.  Steroids for idiopathic sudden sensorineural hearing loss. , 2006, The Cochrane database of systematic reviews.

[62]  S. Rauch.  Clinical practice. Idiopathic sudden sensorineural hearing loss. , 2008, The New England journal of medicine.

[63]  J. Ito,et al.  Drug Delivery to the Cochlea Using PLGA Nanoparticles , 2005, The Laryngoscope.

[64]  J. Fiering,et al.  Local drug delivery with a self-contained, programmable, microfluidic system , 2009, Biomedical microdevices.

[65]  Jeffrey T Borenstein,et al.  Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[66]  K. Brookler,et al.  Etidronate for the Neurotologic Symptoms of Otosclerosis: Preliminary Study , 1997, Ear, nose, & throat journal.

[67]  M. Kenna,et al.  Phosphorylcholine-coated antibiotic tympanostomy tubes: are post-tube placement complications reduced? , 2008, International journal of pediatric otorhinolaryngology.

[68]  E. Fowler.  Streptomycin treatment of vertigo. , 1948, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology.

[69]  Josef M. Miller,et al.  Chronic drug infusion into the scala tympani of the guinea pig cochlea , 1992, Journal of Neuroscience Methods.

[70]  J. Nadol,et al.  Is Word Recognition Correlated With the Number of Surviving Spiral Ganglion Cells and Electrode Insertion Depth in Human Subjects With Cochlear Implants? , 2005, The Laryngoscope.

[71]  M. Liberman,et al.  BMP4 induction of sensory neurons from human embryonic stem cells and reinnervation of sensory epithelium , 2007, The European journal of neuroscience.

[72]  M. Behlke.  Progress towards in Vivo Use of siRNAs , 2006, Molecular Therapy.

[73]  D. Borkholder.  State-of-the-art mechanisms of intracochlear drug delivery , 2008, Current opinion in otolaryngology & head and neck surgery.

[74]  Thomas Lenarz,et al.  Combined Electroacoustic Stimulation in Conventional Candidates for Cochlear Implantation , 2006, Audiology and Neurotology.

[75]  H. Schuknecht.  Ablation therapy for the relief of meniere's disease , 1956, The Laryngoscope.

[76]  F. Byl,et al.  The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. , 1980, Archives of otolaryngology.

[77]  R. Cowan,et al.  Effects of steroids and lubricants on electrical impedance and tissue response following cochlear implantation , 2007, Cochlear implants international.

[78]  H. Staecker,et al.  Steroid Perfusion of the Inner Ear for Sudden Sensorineural Hearing Loss after Failure of Conventional Therapy: A Pilot Study , 2002, Acta oto-laryngologica.

[79]  Perry F. Bartlett,et al.  LIF is more potent than BDNF in promoting neurite outgrowth of mammalian auditory neurons in vitro , 2001, Neuroreport.

[80]  G. Hornyak.  Nanotechnology in otolaryngology. , 2005, Otolaryngologic clinics of North America.

[81]  Adrian James,et al.  Menière's disease. , 2007, BMJ clinical evidence.

[82]  L. Minor,et al.  Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy. , 1999, The American journal of otology.

[83]  B. Blakley,et al.  Post—Tympanostomy Tube Otorrhea: A Meta-Analysis , 2006, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[84]  Sharon G. Kujawa,et al.  Development of a Microfluidics-Based Intracochlear Drug Delivery Device , 2009, Audiology and Neurotology.

[85]  H. Sudhoff,et al.  Transtympanic corticoid therapy for acute profound hearing loss , 2005, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[86]  J. Ito,et al.  Survival of neural stem cells in the cochlea. , 2001, Acta oto-laryngologica.

[87]  Juichi Ito,et al.  Novel Strategy for Treatment of Inner Ears using a Biodegradable Gel , 2005, The Laryngoscope.

[88]  E. Sakata,et al.  Treatment of vestibular disorders. , 1991, Acta oto-laryngologica. Supplementum.

[89]  L. Fisher,et al.  Intratympanic Steroid Injection for Treatment of Idiopathic Sudden Hearing Loss , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[90]  G. Brookes.  Medical Management of Meniere's Disease , 1997, Ear, nose, & throat journal.

[91]  F. Linthicum,et al.  Extraneous round Window Membranes and Plugs: Possible Effect on Intratympanic Therapy , 2000, The Annals of otology, rhinology, and laryngology.

[92]  H. Eastwood,et al.  Effects of Round Window Dexamethasone on Residual Hearing in a Guinea Pig Model of Cochlear Implantation , 2007, Audiology and Neurotology.

[93]  G. Moonen,et al.  NT-3 has a tropic effect on process outgrowth by postnatal auditory neurones in vitro. , 1996, Neuroreport.

[94]  A. Eshraghi,et al.  Biopolymer-Released Dexamethasone Prevents Tumor Necrosis Factor &agr;-Induced Loss of Auditory Hair Cells In Vitro: Implications Toward the Development of a Drug-Eluting Cochlear Implant Electrode Array , 2008, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[95]  M. Hoffer,et al.  Distribution of PLGA nanoparticles in chinchilla cochleae , 2007, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[96]  Gordon G Wallace,et al.  Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. , 2009, Biomaterials.

[97]  J. Turner,et al.  Short Interfering RNA against Transient Receptor Potential Vanilloid 1 Attenuates Cisplatin-Induced Hearing Loss in the Rat , 2008, The Journal of Neuroscience.

[98]  D. Kennedy,et al.  The Effects of Etidronate Disodium on Progressive Hearing Loss from Otosclerosis , 1993, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[99]  C. Beatty,et al.  Long-Term Follow-Up of Transtympanic Gentamicin for Méniére's Syndrome , 2001, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[100]  H. Zenner,et al.  Technical Note on Microcatheter Implantation for Local Inner Ear Drug Delivery: Surgical Technique and Safety Aspects , 2006, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[101]  J. Nadol,et al.  Correlation of Acoustic Threshold Measures and Spiral Ganglion Cell Survival in Severe to Profound Sensorineural Hearing Loss: Implications for Cochlear Implantation , 1998, The Annals of otology, rhinology, and laryngology.

[102]  J. Fayad,et al.  Multichannel Cochlear Implants: Relation of Histopathology to Performance , 2006, The Laryngoscope.

[103]  D. Poe,et al.  Intratympanic gentamicin injection for the treatment of Meniere's disease. , 1998, The American journal of otology.

[104]  Y. Raphael,et al.  Transdifferentiation and its applicability for inner ear therapy , 2007, Hearing Research.

[105]  Huawei Li,et al.  Characterization of proliferating cells from newborn mouse cochleae , 2006, Neuroreport.

[106]  R. Labadie,et al.  Intratympanic Dexamethasone for Sudden Sensorineural Hearing Loss After Failure of Systemic Therapy , 2007, The Laryngoscope.

[107]  G. Lange.  [The intratympanic treatment of Menière's disease with ototoxic antibiotics. A follow-up study of 55 cases (author's transl)]. , 1977, Laryngologie, Rhinologie, Otologie.